Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
07.09.23
/
50%
€1.51
Target price
07.09.24
€3.74
Performance (%)
146.36%
End price
08.09.24
€3.72
Summary
This prediction ended on 08.09.24 with a price of €3.72. With a performance of 146.36% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 8.041% | 8.041% | -5.135% |
| iShares Core DAX® | 1.803% | 0.496% | 18.553% |
| iShares Nasdaq 100 | 0.429% | -0.410% | 8.908% |
| iShares Nikkei 225® | 0.708% | -3.799% | 12.088% |
| iShares S&P 500 | 0.288% | -0.218% | 3.736% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.67
01.04.24
01.04.24
-
01.04.25
01.04.25
71.74%
02.04.25
02.04.25
